Bevacizumab for ROP.
Michael
M
Blair
Michael J
MJ
Shapiro
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004059:Diffusion of Innovation; D006801:Humans; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000517:prevention & control*; D012178:Retinopathy of Prematurity / Q000150:complications*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal